(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-二氟苯基)環(huán)丙基]氨基]-5-丙硫基三唑并[4,5-d]嘧啶-3-基]-5-(2-羥乙氧基)-1,2-環(huán)戊二醇;替卡格雷;
Brilinta;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;TICARGRELOR;Ticagrelor;
用途
原料藥,用于減少急性冠脈綜合征(ACS)患者的心血管死亡和心臟病發(fā)作。
陜西締都醫(yī)藥化工有限公司
聯(lián)系商家時(shí)請?zhí)峒癱hemicalbook,有助于交易順利完成!
陜西締都醫(yī)藥